Why Amgen’s Weight-Loss News Just Sent Lilly To A Record High
Amgen (AMGN) stock went down on Monday, while Eli Lilly (LLY) stock hit a record high after the biotech company announced that its experimental weight-loss drug showed promising results over 150 days.